sibo glp-1 nausea: How to handle GLP-1s' most common side effect ACG 2025 Annual Meeting Posters

Diarrhea affects up to 20% of people taking semaglutide during the first weeks of treatment

Prospective trials are warranted to confirm these observations.

These medications enable cause-specific management of obesity complications.

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity.

If you've ever had to draw the curtains, silence your phone and crawl into bed because a migraine has taken over your day, you know this isn't "just a headache." Migraines can steal hours, derail plans and leave you exhausted long after the pounding finally stops

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity